DNA/RNA

Description
Spans 365 kb; 5 exons.
Transcription
A major transcript of 7.5 kb.
Protein
Description 1153 aa, 125 kDa; conserved N-terminal basic domain (aa 29-92) which binds to the ankyrin repeat domain of Notch receptors; two acidic domains (aa 263-360 and 1124-1153) and a C-terminal transcriptional activation domain.
Expression
Widely expressed.
Localisation
Nuclear granules. 
Implicated in
Mucoepidermoid carcinoma with t(11;19)(q21-22;p13) Disease -Most common type of malignant salivary gland tumor; -Second most frequent lung tumor of bronchial gland origin; -Rare tumour in the thyroid. The t(11;19) was found in samples from the three different sites. Prognosis -Mucoepidermoid carcinomas have an unpredictable behaviour.
-The CRTC1-MAML2 fusion transcript was found equally in low, intermediate and high grade tumours; however, tumours lacking the fusion transcript were significantly associated with metastases; they may represent a subset of aggressive tumours. -In another study, the median survival for fusionpositive patients was greater than 10 years compared to 1.6 years for fusion-negative patients. Hybrid/Mutated Gene CRTC1-MAML2; exon 1 of CRTC1 fused to exons 2-5 of MAML2. Note: CRTC1 is also known as MECT1, or WAMTP1. Warthin's tumor with t(11;19)(q21-22;p13) Note: In rare instances mucoepidermoid carcinoma may arise from or coexist with Warthin's tumors. Disease Warthin's tumor is a salivary gland neoplasm consisting of benign epithelial and lymphoid components; malignant transformation is extremely rare.
Abnormal Protein
Hybrid/Mutated Gene
CRTC1-MAML2
Clear cell hidradenomas of the skin with t(11;19)(q21-22;p13) Disease Clear cell hidradenomas of the skin are benign sweat gland tumors of eccrine duct origin. Hybrid/Mutated Gene CRTC1-MAML2; exon 1 of CRTC1 fused to exons 2 of MAML2. 
inv(11)(q21q23) in therapy related leukemias
To be noted
Note: It is amazing that a similar fusion transcript (CRTC1-MAML2) can be seen both in a benign and in a malignant tumour of the same organ: Warthin's tumor, a benign salivary gland neoplasm, and mucoepidermoid carcinoma of the salivary gland: either another event differentiate the two, or the genetic event takes place in different cell types or in a given cell type at different states of differenciation. It has been hypothezised that CRTC1-MAML2 fusion is etiologically linked to benign and low-grade malignant tumors originating from diverse exocrine glands rather than being linked to a separate tumor entity.
